Showing 1–12 of 24 results
Enbrel
300,00 € – 332,00 €Therapeutic TNF-α-inhibitor from the original Enbrel commercial drug targeting the TNF-α-antigen.
Humira
300,00 € – 610,00 €Therapeutic TNF-α-antibody from the original Humira commercial drug targeting the TNF-α-antigen, also referred to as Humira antibody.
Gazyvaro
300,00 € – 748,00 €Therapeutic CD20-antibody from the original Gazyvaro commercial drug targeting the CD20-antigen, also referred to as Gazyvaro antibody.
Keytruda
300,00 € – 825,00 €Therapeutic PD-1-antibody from the original Keytruda commercial drug targeting the PD-1-antigen, also referred to as Keytruda antibody.
Erbitux
273,00 € – 300,00 €Therapeutic EGFR-antibody from the original Erbitux commercial drug targeting the EGFR-antigen, also referred to as Erbitux antibody.
Yervoynew
961,00 €Therapeutic CTLA4-antibody from the original commercial drug Yervoy targeting the CTLA4-antigen (CD152), also referred to as Iplimumab antibody. This antibody is available with the original certificate of analysis (CoA).
Perjetanew
633,00 €Therapeutic HER2-antibody from the original commercial drug Perjeta targeting the HER2-antigen, also referred to as Pertuzumab antibody. This antibody is available with the original certificate of analysis (CoA).
Tecentriqnew
879,00 €
Imfinzi
197,00 €Therapeutic PD-L1-antibody from the original commercial drug Imfinzi targeting the PD-L1-antigen, also referred to as Durvalumab antibody.
Bavencio
301,00 €Therapeutic PD-L1-antibody from the original commercial drug Bavencio targeting the PD-L1-antigen, also referred to as Avelumab antibody.
Opdivo
299,00 € – 300,00 €Therapeutic PD-1-antibody from the original Opdivo commercial drug targeting the PD-1-antigen, also referred to as Opdivo antibody.
